Correction for Kuroda et al., Bim and Bad mediate imatinib-induced killing of Bcr/Abl⁺ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

medical sciences. For the article “Bim and Bad mediate imatinib-induced killing of Bcr/Abl⁺ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic,” by Junya Kuroda, Hamsa Puthalakath, Mark S. Cragg, Priscilla N. Kelly, Philippe Bouillet, David C. S. Huang, Shinya Kimura, Oliver G. Ottmann, Brian J. Druker, Andreas Villunger, Andrew W. Roberts and Andreas Strasser, which appeared in issue 40, October 3, 2006, of Proc Natl Acad Sci USA (103:14907–14912; first published September 22, 2006; 10.1073/pnas.0606176103), the authors note that the affiliation information for Andreas Villunger was incorrect in part. The correct institution name is “Innsbruck Medical University.”